Related Experiment Video
Updated: Jun 27, 2025
05:37
An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
2.0K
Competing risks and multivariate outcomes in epidemiological and clinical trial research
1Fred Hutchinson Cancer Center, 1100 Fairview Ave N., Seattle, WA, 98109, USA. rprentic@WHI.org.
Lifetime Data Analysis
|May 6, 2024
Summary
This study introduces new data analysis methods for clinical outcomes with competing risks, focusing on identifiable marginal hazard rates. These methods enhance survival function estimation for better clinical research insights.
Area of Science:
- Biostatistics
- Clinical Epidemiology
- Survival Analysis
Background:
- Analyzing clinical outcomes with competing risks is challenging due to hypothetical inference targets.
- Existing methods often require strong assumptions for data identifiability.
Purpose of the Study:
- To present data analysis methods based on marginal hazard rates for competing risks.
- To provide identifiable joint survival function estimators for clinical outcomes.
Main Methods:
- Utilizing single and higher dimensional marginal hazard rates.
- Developing joint survival function estimators for various clinical outcomes.
- Applying methods to simulations and Women's Health Initiative data.
Main Results:
- Demonstrated identifiability of marginal hazard rates under independent censoring.
- Illustrated the application of developed methods using simulations and real-world data.
- Provided a foundation for addressing complex data analysis questions in clinical research.
Conclusions:
- Marginal hazard rate-based methods offer identifiable solutions for competing risks analysis.
- These methods improve survival function estimation for clinical and cohort studies.
- Further research is needed to expand the application and understanding of these techniques.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
01:27Confounding in Epidemiological Studies
164
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
164
01:26Introduction to Epidemiology
720
Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
720
01:21Causality in Epidemiology
395
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
395
01:25Strategies for Assessing and Addressing Confounding
93
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
93
01:12Hazard Ratio
115
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
115